Breaking News Instant updates and real-time market news.

TSLA

Tesla

$620.71 /

-2.7 (-0.43%)

, NIO

Nio

$46.50 /

-0.46 (-0.98%)

06:57
06/22/21
06/22
06:57
06/22/21
06:57

Electric vehicles will represent 94% of new car sales by 2040, says Piper

After assembling a brand-by-brand, region-by-region forecast, Piper Sandler analyst Alexander Potter thinks battery electric vehicles will represent 18% of new vehicle sales in 2025, 45% in 2030 and 94% by 2040. This equates to 18M units in 2025, 45M units in 2030 and 81M units in 2040, Potter tells investors in a research note. He believes China and Europe should lead the transition, with battery electric vehicles representing around a quarter of sales in 2025. By the mid/late 2020s, the analyst thinks all global regions "will be embracing BEVs with gusto." He expects Tesla (TSLA) and newly-formed battery electric vehicles specialists to win share in the coming years. Among incumbents, Volkswagen (VWAGY), General Motors (GM) and Hyundai Motor (HYMTF) are best positioned, says Potter. Tesla is still his favorite way to invest in rising battery electric vehicle sales.

TSLA

Tesla

$620.71 /

-2.7 (-0.43%)

NIO

Nio

$46.50 /

-0.46 (-0.98%)

VWAGY

Volkswagen

$35.09 /

+1.24 (+3.66%)

GM

General Motors

$59.30 /

+0.57 (+0.97%)

HYMTF

Hyundai Motor

$51.00 /

+0.31 (+0.61%)

NIU

Niu Technologies

$30.46 /

-1.54 (-4.81%)

APTV

Aptiv

$150.47 /

+3.18 (+2.16%)

  • 22

    Jun

  • 28

    Jun

  • 31

    Aug

  • 14

    Dec

TSLA Tesla
$620.71 /

-2.7 (-0.43%)

06/14/21 Canaccord
Tesla price target lowered to $812 from $974 at Canaccord
06/11/21 Credit Suisse
Tesla's Model S Plaid reinforces brand DNA, says Credit Suisse
06/11/21 Goldman Sachs
Goldman says Tesla's Model S Plaid helps illustrate technology leadership
06/08/21 GLJ Research
Tesla's China orders down 69% in Q2 versus Q1, says GLJ Research
NIO Nio
$46.50 /

-0.46 (-0.98%)

06/08/21 Bocom
Nio initiated with a Buy at Bocom
06/07/21 Wedbush
Wedbush remains 'firmly bullish' on Tesla, EV thesis despite speed bumps
06/01/21
Fly Intel: Top five analyst upgrades
06/01/21 Citi
Nio upgraded to Buy from Neutral at Citi
VWAGY Volkswagen
$35.09 /

+1.24 (+3.66%)

05/20/21 Citi
Volkswagen resumed with a Buy at Citi
05/10/21 Wedbush
Tesla demand looks robust so far in Q2 despite rising competition, says Wedbush
05/07/21 JPMorgan
Volkswagen price target lowered to EUR 245 from EUR 255 at JPMorgan
05/07/21 RBC Capital
Volkswagen price target raised to EUR 290 from EUR 277 at RBC Capital
GM General Motors
$59.30 /

+0.57 (+0.97%)

06/22/21 Barclays
General Motors price target raised to $74 from $70 at Barclays
06/16/21 Citi
Citi sees path to over $100 per share for GM after guidance and EV spending hike
06/07/21 Barclays
General Motors price target raised to $70 from $66 at Barclays
06/04/21 JPMorgan
General Motors price target raised to $73 from $71 at JPMorgan
HYMTF Hyundai Motor
$51.00 /

+0.31 (+0.61%)

03/04/21 Goldman Sachs
Hyundai Motor initiated with a Buy at Goldman Sachs
02/09/21 Craig-Hallum
Velodyne target cut to $29 at Craig-Hallum as 'lower visibility' reasons emerge
02/04/21 Wedbush
Apple Car deal with Hyundai could be around the corner, says Wedbush
NIU Niu Technologies
$30.46 /

-1.54 (-4.81%)

04/15/21 Piper Sandler
Niu Technologies price target raised to $47 from $38 at Piper Sandler
03/05/21 Daiwa
Niu Technologies initiated with an Outperform at Daiwa
03/03/21 Citi
Niu Technologies price target raised to $48 from $37 at Citi
01/15/21 Needham
Niu Technologies price target raised to $46 from $36 at Needham
APTV Aptiv
$150.47 /

+3.18 (+2.16%)

06/02/21 Morgan Stanley
Oil price rise 'significantly improves' EV payback math, says Morgan Stanley
05/13/21 Morgan Stanley
Aptiv price target raised to $205 from $200 at Morgan Stanley
05/10/21 Deutsche Bank
Aptiv price target raised to $165 from $162 at Deutsche Bank
05/07/21 RBC Capital
Aptiv price target raised to $187 from $174 at RBC Capital

TODAY'S FREE FLY STORIES

Earnings
Ritchie Bros. reports Q2 EPS 55c, consensus 61c » 17:13
08/05/21
08/05
17:13
08/05/21
17:13
RBA

Ritchie Bros.

$59.50 /

+1.12 (+1.92%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RBA Ritchie Bros.
$59.50 /

+1.12 (+1.92%)

RBA Ritchie Bros.
$59.50 /

+1.12 (+1.92%)

05/12/21 National Bank
Ritchie Bros. downgraded to Sector Perform on valuation at National Bank
05/11/21 National Bank
Ritchie Bros. downgraded to Sector Perform from Outperform at National Bank
04/21/21 OTR Global
Ritchie Bros. downgraded to Mixed from Positive at OTR Global
02/24/21
Fly Intel: Top five analyst upgrades
RBA Ritchie Bros.
$59.50 /

+1.12 (+1.92%)

Earnings
Kura Oncology reports Q2 EPS (51c), consensus (49c) » 17:12
08/05/21
08/05
17:12
08/05/21
17:12
KURA

Kura Oncology

$18.33 /

+0.71 (+4.03%)

Cash, cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KURA Kura Oncology
$18.33 /

+0.71 (+4.03%)

KURA Kura Oncology
$18.33 /

+0.71 (+4.03%)

05/04/21 Credit Suisse
Kura Oncology assumed with an Outperform at Credit Suisse
04/26/21 Credit Suisse
Kura Oncology assumed with an Outperform at Credit Suisse
02/24/21 Piper Sandler
Kura Oncology price target lowered to $30 from $34 at Piper Sandler
02/24/21 H.C. Wainwright
H.C. Wainwright trims Kura Oncology price target to $43 after Q4 report
KURA Kura Oncology
$18.33 /

+0.71 (+4.03%)

  • 09
    Dec
KURA Kura Oncology
$18.33 /

+0.71 (+4.03%)

Earnings
PHX Minerals reports Q2 EPS (5c), consensus 4c » 17:12
08/05/21
08/05
17:12
08/05/21
17:12
PHX

PHX Minerals

$2.89 /

+0.04 (+1.40%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PHX PHX Minerals
$2.89 /

+0.04 (+1.40%)

PHX PHX Minerals
$2.89 /

+0.04 (+1.40%)

05/14/21 Seaport Global
PHX Minerals initiated with a Buy at Seaport Global
05/03/21
Fly Intel: Top five analyst initiations
05/03/21 Northland
PHX Minerals initiated with an Outperform at Northland
10/08/20 Stifel
Panhandle Oil & Gas initiated with a Buy at Stifel
PHX PHX Minerals
$2.89 /

+0.04 (+1.40%)

  • 16
    Apr
  • 28
    Aug
PHX PHX Minerals
$2.89 /

+0.04 (+1.40%)

Hot Stocks
Trian's Peltz to conclude service on P&G's board at end of term » 17:11
08/05/21
08/05
17:11
08/05/21
17:11
PG

Procter & Gamble

$142.50 /

+0.08 (+0.06%)

The Procter & Gamble…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PG Procter & Gamble
$142.50 /

+0.08 (+0.06%)

PG Procter & Gamble
$142.50 /

+0.08 (+0.06%)

08/02/21 Truist
Procter & Gamble price target raised to $145 from $140 at Truist
08/02/21 Morgan Stanley
Procter & Gamble price target raised to $160 from $155 at Morgan Stanley
08/02/21 RBC Capital
Procter & Gamble price target raised to $139 from $130 at RBC Capital
08/02/21 Credit Suisse
Procter & Gamble price target raised to $145 from $135 at Credit Suisse
PG Procter & Gamble
$142.50 /

+0.08 (+0.06%)

PG Procter & Gamble
$142.50 /

+0.08 (+0.06%)

PG Procter & Gamble
$142.50 /

+0.08 (+0.06%)

PG Procter & Gamble
$142.50 /

+0.08 (+0.06%)

Earnings
Pembina Pipeline sees FY21 adjusted EBITDA C$3.3B-C$3.4B  17:11
08/05/21
08/05
17:11
08/05/21
17:11
PBA

Pembina Pipeline

$32.54 /

-0.03 (-0.09%)

 
ShowHide Related Items >><<
PBA Pembina Pipeline
$32.54 /

-0.03 (-0.09%)

PBA Pembina Pipeline
$32.54 /

-0.03 (-0.09%)

07/28/21 BMO Capital
Pembina Pipeline resumed with a Market Perform at BMO Capital
06/18/21 CIBC
Pembina Pipeline upgraded to Outperformer from Neutral at CIBC
06/16/21 National Bank
Pembina Pipeline price target raised to C$40 from C$39 at National Bank
05/10/21 RBC Capital
Pembina Pipeline price target raised to C$42 from C$40 at RBC Capital
PBA Pembina Pipeline
$32.54 /

-0.03 (-0.09%)

PBA Pembina Pipeline
$32.54 /

-0.03 (-0.09%)

Earnings
Harpoon Therapeutics reports Q2 EPS (52c), consensus (43c) » 17:11
08/05/21
08/05
17:11
08/05/21
17:11
HARP

Harpoon Therapeutics

$9.90 /

+0.07 (+0.71%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HARP Harpoon Therapeutics
$9.90 /

+0.07 (+0.71%)

HARP Harpoon Therapeutics
$9.90 /

+0.07 (+0.71%)

07/12/21 Roth Capital
Roth adds more 'SMID-cap' names to second half top picks
06/08/21
Fly Intel: Top five analyst downgrades
06/08/21 Citi
Harpoon Therapeutics downgraded to Neutral from Buy at Citi
06/07/21 Roth Capital
Harpoon prostate cancer data 'very encouraging,' says Roth Capital
HARP Harpoon Therapeutics
$9.90 /

+0.07 (+0.71%)

  • 07
    Jan
Earnings
Pembina Pipeline reports Q2 EPS C$0.39 vs, C$0.40 a year ago » 17:11
08/05/21
08/05
17:11
08/05/21
17:11
PBA

Pembina Pipeline

$32.54 /

-0.03 (-0.09%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PBA Pembina Pipeline
$32.54 /

-0.03 (-0.09%)

PBA Pembina Pipeline
$32.54 /

-0.03 (-0.09%)

07/28/21 BMO Capital
Pembina Pipeline resumed with a Market Perform at BMO Capital
06/18/21 CIBC
Pembina Pipeline upgraded to Outperformer from Neutral at CIBC
06/16/21 National Bank
Pembina Pipeline price target raised to C$40 from C$39 at National Bank
05/10/21 RBC Capital
Pembina Pipeline price target raised to C$42 from C$40 at RBC Capital
PBA Pembina Pipeline
$32.54 /

-0.03 (-0.09%)

PBA Pembina Pipeline
$32.54 /

-0.03 (-0.09%)

Earnings
LiveRamp sees FY22 revenue about $522M, consensus $509M  17:10
08/05/21
08/05
17:10
08/05/21
17:10
RAMP

LiveRamp

$38.85 /

+0.15 (+0.39%)

 
ShowHide Related Items >><<
RAMP LiveRamp
$38.85 /

+0.15 (+0.39%)

RAMP LiveRamp
$38.85 /

+0.15 (+0.39%)

07/15/21 Susquehanna
LiveRamp well positioned to capture CTV opportunity, says Susquehanna
07/15/21 Susquehanna
LiveRamp well positioned to capture CTV opportunity, says Susquehanna
06/25/21 Macquarie
Google cookie delay removes near-term overhang on adtech, says Macquarie
06/11/21 Morgan Stanley
LiveRamp news 'incrementally negative for the stock,' says Morgan Stanley
RAMP LiveRamp
$38.85 /

+0.15 (+0.39%)

  • 10
    Feb
RAMP LiveRamp
$38.85 /

+0.15 (+0.39%)

Earnings
Floor & Decor sees FY21 CapEx $455M-$475M » 17:10
08/05/21
08/05
17:10
08/05/21
17:10
FND

Floor & Decor

$127.00 /

+1.475 (+1.18%)

Sees FY21 tax rate…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FND Floor & Decor
$127.00 /

+1.475 (+1.18%)

FND Floor & Decor
$127.00 /

+1.475 (+1.18%)

07/20/21 Wolfe Research
Mister Car Wash initiated with an Outperform at Wolfe Research
06/03/21 Jefferies
Floor & Decor price target raised to $136 from $133 at Jefferies
05/18/21 Credit Suisse
Floor & Decor assumed with an Outperform at Credit Suisse
05/07/21 Barclays
Floor & Decor price target raised to $125 from $110 at Barclays
FND Floor & Decor
$127.00 /

+1.475 (+1.18%)

  • 11
    Aug
FND Floor & Decor
$127.00 /

+1.475 (+1.18%)

Earnings
LiveRamp sees Q2 revenue $124M, consensus $121.7M  17:10
08/05/21
08/05
17:10
08/05/21
17:10
RAMP

LiveRamp

$38.85 /

+0.15 (+0.39%)

 
ShowHide Related Items >><<
RAMP LiveRamp
$38.85 /

+0.15 (+0.39%)

RAMP LiveRamp
$38.85 /

+0.15 (+0.39%)

07/15/21 Susquehanna
LiveRamp well positioned to capture CTV opportunity, says Susquehanna
07/15/21 Susquehanna
LiveRamp well positioned to capture CTV opportunity, says Susquehanna
06/25/21 Macquarie
Google cookie delay removes near-term overhang on adtech, says Macquarie
06/11/21 Morgan Stanley
LiveRamp news 'incrementally negative for the stock,' says Morgan Stanley
RAMP LiveRamp
$38.85 /

+0.15 (+0.39%)

  • 10
    Feb
RAMP LiveRamp
$38.85 /

+0.15 (+0.39%)

Earnings
Floor & Decor reports Q2 adjusted EPS 73c, consensus 61c » 17:10
08/05/21
08/05
17:10
08/05/21
17:10
FND

Floor & Decor

$127.00 /

+1.475 (+1.18%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FND Floor & Decor
$127.00 /

+1.475 (+1.18%)

FND Floor & Decor
$127.00 /

+1.475 (+1.18%)

07/20/21 Wolfe Research
Mister Car Wash initiated with an Outperform at Wolfe Research
06/03/21 Jefferies
Floor & Decor price target raised to $136 from $133 at Jefferies
05/18/21 Credit Suisse
Floor & Decor assumed with an Outperform at Credit Suisse
05/07/21 Barclays
Floor & Decor price target raised to $125 from $110 at Barclays
FND Floor & Decor
$127.00 /

+1.475 (+1.18%)

  • 11
    Aug
FND Floor & Decor
$127.00 /

+1.475 (+1.18%)

Earnings
LiveRamp reports Q1 EPS 9c, consensus (2c) » 17:10
08/05/21
08/05
17:10
08/05/21
17:10
RAMP

LiveRamp

$38.85 /

+0.15 (+0.39%)

Reports Q1 revenue $119M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RAMP LiveRamp
$38.85 /

+0.15 (+0.39%)

RAMP LiveRamp
$38.85 /

+0.15 (+0.39%)

07/15/21 Susquehanna
LiveRamp well positioned to capture CTV opportunity, says Susquehanna
07/15/21 Susquehanna
LiveRamp well positioned to capture CTV opportunity, says Susquehanna
06/25/21 Macquarie
Google cookie delay removes near-term overhang on adtech, says Macquarie
06/11/21 Morgan Stanley
LiveRamp news 'incrementally negative for the stock,' says Morgan Stanley
RAMP LiveRamp
$38.85 /

+0.15 (+0.39%)

  • 10
    Feb
RAMP LiveRamp
$38.85 /

+0.15 (+0.39%)

Earnings
Cellectis reports Q2 EPS (80c), consensus (73c) » 17:09
08/05/21
08/05
17:09
08/05/21
17:09
CLLS

Cellectis

$13.78 /

+0.475 (+3.57%)

Reports Q2 revenue $15M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLLS Cellectis
$13.78 /

+0.475 (+3.57%)

CLLS Cellectis
$13.78 /

+0.475 (+3.57%)

04/28/21 Guggenheim
Cellectis downgraded to Neutral on slow progress at Guggenheim
04/28/21 Guggenheim
Cellectis downgraded to Neutral from Buy at Guggenheim
03/16/21 Baird
Cellectis upgraded to Outperform from Neutral at Baird
10/15/20 Baird
Cellectis downgraded to Neutral at Baird
CLLS Cellectis
$13.78 /

+0.475 (+3.57%)

  • 16
    Dec
Earnings
Altair Engineering sees FY21 revenue $512M-518M, consensus $509.5M  17:09
08/05/21
08/05
17:09
08/05/21
17:09
ALTR

Altair Engineering

$70.90 /

+1.84 (+2.66%)

 
ShowHide Related Items >><<
ALTR Altair Engineering
$70.90 /

+1.84 (+2.66%)

ALTR Altair Engineering
$70.90 /

+1.84 (+2.66%)

07/26/21 Rosenblatt
Altair Engineering initiated with a Buy at Rosenblatt
05/14/21
Fly Intel: Top five analyst initiations
05/14/21 Goldman Sachs
Altair Engineering assumed with a Neutral at Goldman Sachs
05/07/21 William Blair
Altair upgraded to Outperform from Market Perform at William Blair
ALTR Altair Engineering
$70.90 /

+1.84 (+2.66%)

ALTR Altair Engineering
$70.90 /

+1.84 (+2.66%)

Earnings
Mirati Therapeutics reports Q2 EPS ($3.23), consensus ($2.40) » 17:09
08/05/21
08/05
17:09
08/05/21
17:09
MRTX

Mirati Therapeutics

$164.25 /

+5.92 (+3.74%)

"We continue to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRTX Mirati Therapeutics
$164.25 /

+5.92 (+3.74%)

MRTX Mirati Therapeutics
$164.25 /

+5.92 (+3.74%)

06/04/21 Citi
Mirati Therapeutics upgraded to Buy from Neutral at Citi
05/17/21
Fly Intel: Top five analyst downgrades
05/17/21 Oppenheimer
Mirati Therapeutics downgraded to Perform from Outperform at Oppenheimer
05/17/21 Oppenheimer
Mirati Therapeutics downgraded to Perform from Outperform at Oppenheimer
MRTX Mirati Therapeutics
$164.25 /

+5.92 (+3.74%)

  • 28
    Oct
MRTX Mirati Therapeutics
$164.25 /

+5.92 (+3.74%)

Earnings
Arena Pharmaceuticals reports Q2 EPS ($2.40), consensus ($2.19) » 17:08
08/05/21
08/05
17:08
08/05/21
17:08
ARNA

Arena Pharmaceuticals

$62.00 /

+2.685 (+4.53%)

"With today's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ARNA Arena Pharmaceuticals
$62.00 /

+2.685 (+4.53%)

ARNA Arena Pharmaceuticals
$62.00 /

+2.685 (+4.53%)

05/18/21 Goldman Sachs
Arena Pharmaceuticals initiated with a Buy at Goldman Sachs
04/27/21 Citi
Arena Pharmaceuticals initiated with a Buy at Citi
04/26/21 Credit Suisse
Arena Pharmaceuticals assumed with an Outperform at Credit Suisse
04/06/21 Evercore ISI
Evercore starts 'compelling' Arena spinoff Longboard at Outperform
ARNA Arena Pharmaceuticals
$62.00 /

+2.685 (+4.53%)

ARNA Arena Pharmaceuticals
$62.00 /

+2.685 (+4.53%)

Earnings
Aurinia Pharmaceuticals reports Q2 EPS (37c), consensus (14c) » 17:08
08/05/21
08/05
17:08
08/05/21
17:08
AUPH

Aurinia Pharmaceuticals

$11.71 /

+0.245 (+2.14%)

Reports Q2 revenue $6.6M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AUPH Aurinia Pharmaceuticals
$11.71 /

+0.245 (+2.14%)

AUPH Aurinia Pharmaceuticals
$11.71 /

+0.245 (+2.14%)

05/24/21 H.C. Wainwright
Aurinia reported positive data as competitors 'stumble,' says H.C. Wainwright
05/07/21 RBC Capital
Aurinia Pharmaceuticals price target lowered to $23 from $26 at RBC Capital
01/26/21 RBC Capital
Aurinia Pharmaceuticals price target raised to $28 from $20 at RBC Capital
01/26/21 Cantor Fitzgerald
Aurinia Pharmaceuticals price target raised to $34 from $27 at Cantor Fitzgerald
AUPH Aurinia Pharmaceuticals
$11.71 /

+0.245 (+2.14%)

AUPH Aurinia Pharmaceuticals
$11.71 /

+0.245 (+2.14%)

AUPH Aurinia Pharmaceuticals
$11.71 /

+0.245 (+2.14%)

Hot Stocks
Corteva announces new $1.5B share repurchase plan » 17:08
08/05/21
08/05
17:08
08/05/21
17:08
CTVA

Corteva

$41.44 /

-0.87 (-2.06%)

Corteva announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CTVA Corteva
$41.44 /

-0.87 (-2.06%)

CTVA Corteva
$41.44 /

-0.87 (-2.06%)

06/24/21 Deutsche Bank
Corteva shares could rise 50% by end of 2023, says Deutsche Bank
05/26/21 JPMorgan
Corteva shares have been 'over-penalized,' says JPMorgan
05/17/21 Argus
Corteva price target raised to $54 from $51 at Argus
05/10/21 BofA
Corteva double downgraded to Underperform at BofA on litigation risks
CTVA Corteva
$41.44 /

-0.87 (-2.06%)

CTVA Corteva
$41.44 /

-0.87 (-2.06%)

Earnings
Altair Engineering sees Q3 revenue $112M-$115M , consensus $111.07M  17:08
08/05/21
08/05
17:08
08/05/21
17:08
ALTR

Altair Engineering

$70.90 /

+1.84 (+2.66%)

 
ShowHide Related Items >><<
ALTR Altair Engineering
$70.90 /

+1.84 (+2.66%)

ALTR Altair Engineering
$70.90 /

+1.84 (+2.66%)

07/26/21 Rosenblatt
Altair Engineering initiated with a Buy at Rosenblatt
05/14/21
Fly Intel: Top five analyst initiations
05/14/21 Goldman Sachs
Altair Engineering assumed with a Neutral at Goldman Sachs
05/07/21 William Blair
Altair upgraded to Outperform from Market Perform at William Blair
ALTR Altair Engineering
$70.90 /

+1.84 (+2.66%)

ALTR Altair Engineering
$70.90 /

+1.84 (+2.66%)

Earnings
Consolidated Edison backs FY21 adjusted EPS view $4.15-$4.35, consensus $4.26  17:07
08/05/21
08/05
17:07
08/05/21
17:07
ED

Consolidated Edison

$75.30 /

+0.4 (+0.53%)

 
ShowHide Related Items >><<
ED Consolidated Edison
$75.30 /

+0.4 (+0.53%)

ED Consolidated Edison
$75.30 /

+0.4 (+0.53%)

07/20/21
Fly Intel: Top five analyst downgrades
07/20/21 KeyBanc
Consolidated Edison downgraded to Underweight from Sector Weight at KeyBanc
06/14/21 Mizuho
Consolidated Edison price target raised to $78 from $68 at Mizuho
05/25/21 Barclays
Consolidated Edison price target raised to $75 from $69 at Barclays
ED Consolidated Edison
$75.30 /

+0.4 (+0.53%)

  • 16
    Jun
  • 02
    Dec
ED Consolidated Edison
$75.30 /

+0.4 (+0.53%)

Earnings
Flowserve raises FY21 adjusted EPS view to $1.45-$1.65 from $1.40-$1.60 » 17:07
08/05/21
08/05
17:07
08/05/21
17:07
FLS

Flowserve

$42.92 /

+0.21 (+0.49%)

Consensus $1.64. Raises…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FLS Flowserve
$42.92 /

+0.21 (+0.49%)

FLS Flowserve
$42.92 /

+0.21 (+0.49%)

07/08/21
Fly Intel: Top five analyst upgrades
07/08/21 Credit Suisse
Flowserve upgraded to Outperform from Neutral at Credit Suisse
07/07/21 Cowen
Cowen upgrades Flowserve into 'favorable operational period'
07/07/21 Cowen
Flowserve upgraded to Outperform from Market Perform at Cowen
FLS Flowserve
$42.92 /

+0.21 (+0.49%)

FLS Flowserve
$42.92 /

+0.21 (+0.49%)

Earnings
Consolidated Edison reports Q2 adjusted EPS 53c, consensus 60c  17:07
08/05/21
08/05
17:07
08/05/21
17:07
ED

Consolidated Edison

$75.30 /

+0.4 (+0.53%)

 
ShowHide Related Items >><<
ED Consolidated Edison
$75.30 /

+0.4 (+0.53%)

ED Consolidated Edison
$75.30 /

+0.4 (+0.53%)

07/20/21
Fly Intel: Top five analyst downgrades
07/20/21 KeyBanc
Consolidated Edison downgraded to Underweight from Sector Weight at KeyBanc
06/14/21 Mizuho
Consolidated Edison price target raised to $78 from $68 at Mizuho
05/25/21 Barclays
Consolidated Edison price target raised to $75 from $69 at Barclays
ED Consolidated Edison
$75.30 /

+0.4 (+0.53%)

  • 16
    Jun
  • 02
    Dec
ED Consolidated Edison
$75.30 /

+0.4 (+0.53%)

Earnings
Barings BDC reports Q2 NII 22c, consensus 22c » 17:07
08/05/21
08/05
17:07
08/05/21
17:07
BBDC

Barings BDC

$10.70 /

+0.045 (+0.42%)

NAV per share as of June…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BBDC Barings BDC
$10.70 /

+0.045 (+0.42%)

BBDC Barings BDC
$10.70 /

+0.045 (+0.42%)

06/25/21
Fly Intel: Top five analyst upgrades
06/25/21 BofA
Barings BDC double-upgraded to Buy from Underperform at BofA
01/21/21 Jefferies
Barings BDC upgraded to Buy ahead of earnings at Jefferies
01/21/21 Jefferies
Barings BDC upgraded to Buy from Hold at Jefferies
BBDC Barings BDC
$10.70 /

+0.045 (+0.42%)

Earnings
Altair Engineering reports Q2 EPS 7c, consensus 1c » 17:06
08/05/21
08/05
17:06
08/05/21
17:06
ALTR

Altair Engineering

$70.90 /

+1.84 (+2.66%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALTR Altair Engineering
$70.90 /

+1.84 (+2.66%)

ALTR Altair Engineering
$70.90 /

+1.84 (+2.66%)

07/26/21 Rosenblatt
Altair Engineering initiated with a Buy at Rosenblatt
05/14/21
Fly Intel: Top five analyst initiations
05/14/21 Goldman Sachs
Altair Engineering assumed with a Neutral at Goldman Sachs
05/07/21 William Blair
Altair upgraded to Outperform from Market Perform at William Blair
ALTR Altair Engineering
$70.90 /

+1.84 (+2.66%)

ALTR Altair Engineering
$70.90 /

+1.84 (+2.66%)

Earnings
Adverum Biotechnologies reports Q2 EPS (45c), consensus (38c) » 17:06
08/05/21
08/05
17:06
08/05/21
17:06
ADVM

Adverum Biotechnologies

$2.41 /

+0.095 (+4.10%)

Cash, cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADVM Adverum Biotechnologies
$2.41 /

+0.095 (+4.10%)

ADVM Adverum Biotechnologies
$2.41 /

+0.095 (+4.10%)

07/23/21
Fly Intel: Top five analyst downgrades
07/23/21 Goldman Sachs
Adverum Biotechnologies downgraded to Neutral from Buy at Goldman Sachs
07/23/21 SVB Leerink
Adverum Biotechnologies price target lowered to $2 from $5
07/23/21 Chardan
Adverum Biotechnologies price target lowered to $3 from $5 at Chardan
ADVM Adverum Biotechnologies
$2.41 /

+0.095 (+4.10%)

  • 13
    Aug
ADVM Adverum Biotechnologies
$2.41 /

+0.095 (+4.10%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.